Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice

Fig. 3

Characterization of BLM-induced pulmonary fibrosis-harboring lungs of wild-type (WT) and Scgb3a2-transgenic (TG) mice. a Number of inflammatory cells in BAL fluids at 3, 6, and 9 weeks post-BLM treatment and PBS control groups collected at 3 weeks. (right panel) Number of monocytes/lymphocytes, neutrophils, and macrophages from 3 weeks post-BLM treatment mice were separately counted. *P < 0.05 by student’s t-test. b qRT-PCR analysis for various mRNA levels. The results are shown as the mean ± SD from N = 7-10. *P < 0.05, **P < 0.01, NS, not significant by student’s t-test

Back to article page